Acupuncture for Oxaliplatin Chemotherapy-Induced Peripheral Neuropathy in Colon Cancer: A Retrospective Case Series

被引:5
作者
Valentine-Davis, Brandy [1 ]
Altshuler, Laurence H. [1 ]
机构
[1] Southwestern Reg Med Ctr Inc, Canc Treatment Ctr Amer, 10109 East 79th St, Tulsa, OK 74133 USA
关键词
Chemotherapy-Induced Peripheral Neuropathy; Acupuncture; Integrative Oncology;
D O I
10.1089/acu.2015.1103
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side-effect resulting from chemotherapy agents. CIPN is a significant concern for patients who have cancer, as CIPN has a negative impact on quality of life and can be a dose-limiting side-effect of chemotherapy, leading to decreased treatment efficacy. Currently, there are very few effective treatments for mitigating CIPN. However, several studies have shown that Traditional Chinese Medicine (TCM)-based acupuncture may be effective for preventing and/or treating CIPN. This article describes the current authors' experience in an integrative oncology setting, illustrating the use of TCM-based acupuncture for treating CIPN resulting from oxaliplatin chemotherapy regimens. Materials and Methods: This was a retrospective case series of 10 patients who were treated by physicians at the Southwestern Regional Medical Center (SRMC) of the Cancer Treatment Centers of America (CTCA) at. At this medical center, advances in cancer treatment are combined with integrative oncology services, such as acupuncture, as a standard of care. Each patient who underwent acupuncture to treat or prevent CIPN received a TCM diagnosis and points were selected on an individual basis for each visit. Verbal consent was received and documented for each patient included in this report. Results: With the use of TCM-based acupuncture, the 10 patients had considerable improvement with respect to prevention and mitigation of symptoms associated with CIPN. Individualized treatment plans that utilized frequent, aggressive acupuncture to increase blood flow to distal points produced the best outcomes in these patients. Conclusions: The current authors' experience suggests that an individualized approach using TCM-based acupuncture may be beneficial in the prevention and treatment of CIPN.
引用
收藏
页码:216 / 223
页数:8
相关论文
共 28 条
[1]  
Benoit E, 2006, GEN PHYSIOL BIOPHYS, V25, P263
[2]   EXPERIMENTAL PERIPHERAL NEUROPATHY INDUCED IN ADULT-RATS BY REPEATED INTRAPERITONEAL ADMINISTRATION OF TAXOL [J].
CAVALETTI, G ;
TREDICI, G ;
BRAGA, M ;
TAZZARI, S .
EXPERIMENTAL NEUROLOGY, 1995, 133 (01) :64-72
[3]   Carboplatin toxic effects on the peripheral nervous system of the rat [J].
Cavaletti, G ;
Fabbrica, D ;
Minoia, C ;
Frattola, L ;
Tredici, G .
ANNALS OF ONCOLOGY, 1998, 9 (04) :443-447
[4]   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[5]   Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy [J].
Donald, Graeme K. ;
Tobin, Irene ;
Stringer, Jacqui .
ACUPUNCTURE IN MEDICINE, 2011, 29 (03) :230-233
[6]   Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis [J].
Finnerup, Nanna B. ;
Attal, Nadine ;
Haroutounian, Simon ;
McNicol, Ewan ;
Baron, Ralf ;
Dworkin, Robert H. ;
Gilron, Ian ;
Haanpaa, Maija ;
Hansson, Per ;
Jensen, Troels S. ;
Kamerman, Peter R. ;
Lund, Karen ;
Moore, Andrew ;
Raja, Srinivasa N. ;
Rice, Andrew S. C. ;
Rowbotham, Michael ;
Sena, Emily ;
Siddall, Philip ;
Smith, Blair H. ;
Wallace, Mark .
LANCET NEUROLOGY, 2015, 14 (02) :162-173
[7]  
Franconi G., 2013, EVID-BASED COMPL ALT, V2013
[8]   Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study [J].
Gewandter, J. S. ;
Fan, L. ;
Magnuson, A. ;
Mustian, K. ;
Peppone, L. ;
Heckler, C. ;
Hopkins, J. ;
Tejani, M. ;
Morrow, G. R. ;
Mohile, S. G. .
SUPPORTIVE CARE IN CANCER, 2013, 21 (07) :2059-2066
[9]   Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer [J].
Giacchetti, S ;
Perpoint, B ;
Zidani, R ;
Le Bail, N ;
Faggiuolo, R ;
Focan, C ;
Chollet, P ;
Llory, JF ;
Letourneau, Y ;
Coudert, B ;
Bertheaut-Cvitkovic, F ;
Larregain-Fournier, D ;
Le Rol, A ;
Walter, S ;
Adam, R ;
Misset, JL ;
Lévi, F .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :136-147
[10]   A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels [J].
Grolleau, F ;
Gamelin, L ;
Boisdron-Celle, M ;
Lapied, B ;
Pelhate, M ;
Gamelin, E .
JOURNAL OF NEUROPHYSIOLOGY, 2001, 85 (05) :2293-2297